Accounting for quality improvement during the conduct of embedded pragmatic clinical trials within healthcare systems: NIH Collaboratory case studies.
Accounting for quality improvement during the conduct of embedded pragmatic clinical trials within healthcare systems: NIH Collaboratory case studies.
复制标题
DOI:
10.1016/j.hjdsi.2020.100432
复制
发表时间:
2021-06
期刊:
影响因子:
--
通讯作者:
Larson EB
中科院分区:
文献类型:
--
作者:
Tuzzio L;Meyers CM;Dember LM;Grudzen CR;Melnick ER;Staman KL;Huang SS;Richards J;DeBar L;Vazquez MA;Green BB;Coronado GD;Jarvik JG;Braciszewski J;Ho PM;Wells BL;James K;Toto R;D'Onofrio G;Volandes A;Kuklinski MR;Catalano RF;Sterling SA;Morse EF;Curtis L;Larson EB
Embedded pragmatic clinical trials (ePCTs) and quality improvement (QI) activities often occur simultaneously within healthcare systems (HCSs). Embedded PCTs within HCSs are conducted to test interventions and provide evidence that may impact public health, health system operations, and quality of care. They are larger and more broadly generalizable than QI initiatives, and may generate what is considered high-quality evidence for potential use in care and clinical practice guidelines. QI initiatives often co-occur with ePCTs and address the same high-impact health questions, and this co-occurrence may dilute or confound the ability to detect change as a result of the ePCT intervention. During the design, pilot, and conduct phases of the large-scale NIH Collaboratory Demonstration ePCTs, many QI initiatives occurred at the same time within the HCSs. Although the challenges varied across the projects, some common, generalizable strategies and solutions emerged, and we share these as case studies. Study teams often need to monitor, adapt, and respond to QI during design and the course of the trial. Routine collaboration between ePCT researchers and health systems stakeholders throughout the trial can help ensure research and QI are optimally aligned to support high-quality patient-centered care.
登录
查看更多内容
影响因子:
3.6
作者:
DeBar, Lynn L.;Kindler, Lindsay;Keefe, Francis J.;Green, Carla A.;Smith, David H.;Deyo, Richard A.;Ames, Katharine;Feldstein, Adrianne
通讯作者:
Feldstein, Adrianne
影响因子:
2.9
作者:
Grudzen, Corita R.;Brody, Abraham A.;Zimny, Erin
通讯作者:
Zimny, Erin
DOI:
10.1177/1740774512443594
发表时间:
2012-06
期刊:
Clinical trials (London, England)
影响因子:
--
作者:
Cohen MS;McCauley M;Sugarman J
通讯作者:
Sugarman J
影响因子:
120.7
作者:
Tricoci, Pierluigi;Allen, Joseph M.;Smith, Sidney C., Jr.
通讯作者:
Smith, Sidney C., Jr.
影响因子:
2.2
作者:
Jarvik, Jeffrey G.;Comstock, Bryan A.;Heagerty, Patrick J.
通讯作者:
Heagerty, Patrick J.